(626) 765-6656

In the Newsroom

Home » Newsroom » U.S. Food and Drug Administration (FDA) Announcement

U.S. Food and Drug Administration (FDA) Announcement

Jul 13, 2021 | Newsroom | 0 comments

Today there was an announcement by the U.S. Food and Drug Administration (FDA) placing a hold on Sigilon Therapeutics’ phase 1/2 study of SIG-001 in patients with severe or moderately severe hemophilia A. Click here for the full story. 

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *